DNTH logo

Dianthus Therapeutics, Inc. (DNTH)

Profile

Full Name

Dianthus Therapeutics, Inc.

Ticker

NASDAQ: DNTH

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 21, 2018

Indexes

Not included

Website

https://dianthustx.com

Employees

78

Key Details

Price

$23.65(+0.98%)

Market cap

$761.25M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$6.24M(+120.63% YoY)

Annual EPS

-$2.55(+69.82% YoY)

PE ratio

-

Next earnings date

Nov 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $23.65
    DNTH price is $23.65

    30-Day Relative Volume

    0.68
    DNTH 30-day relative volume is 0.68

    Price Performance

    Price Today change

    +0.98%
    DNTH price is up +0.98% today

    Price YTD change

    +8.49%
    DNTH price is up +8.49% since January 1st

    Price 1-year change

    -17.1%
    DNTH price is down -17.1% year-on-year

    Price 3-year change

    +1387.42%
    DNTH price is up +1387.42% over the past 3 years

    Price Range

    Price All-time high

    $33.77
    DNTH price is currently -29.97% below its historical high of $33.77

    Price 3-year low

    $0.32
    DNTH price is currently +7290.63% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $761.25M
    DNTH market capitalization is $761.25 million

    Market cap 3-year change

    +12907.73%
    DNTH market capitalization is up +12907.73% over the past 3 years

    Market cap All-time high

    $937.34M
    DNTH market capitalization is currently -18.79% below its historical high of $937.34 million

    Market cap sector rank

    70.23%
    DNTH market capitalization is higher than 70.23% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +9.65%
    DNTH shares outstanding is up +9.65% year-on-year

    Shares Outstanding 3-Year Change

    +774.52%
    DNTH shares outstanding is up +774.52% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.21
    DNTH beta is 1.21

    200-day SMA

    $21.25
    DNTH price is currently +11.27% above its 200-day simple moving average

    50-day SMA

    $19.83
    DNTH price is currently +19.24% above its 50-day simple moving average

    RSI

    67.09
    DNTH 14-day relative strength index is 67.09

    Volume

    0.68
    DNTH 30-day relative volume is 0.68

    ATR

    $1.49
    DNTH average true range is $1.49

    10-day Historical Volatility

    53.85%
    DNTH 10-day historical volatility is 53.85%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $6.24M
    DNTH annual revenue is $6.24 million

    Revenue Analysts estimate

    $2.52M
    DNTH annual revenue is currently +147.90% higher than the consensus analysts' forecast

    Revenue 1-year change

    +120.63%
    DNTH annual revenue is up +120.63% year-on-year

    Revenue Sector rank

    44.52%
    DNTH annual revenue is higher than 44.52% of companies in Healthcare sector

    EPS

    EPS

    -$2.55
    DNTH annual earnings per share is -$2.55

    EPS Analysts estimate

    -$3.37
    DNTH annual earnings per share is currently -24.39% lower than the consensus analysts' forecast

    EPS 1-year change

    +69.82%
    DNTH annual earnings per share is up +69.82% year-on-year

    EPS Sector rank

    33.11%
    DNTH annual earnings per share is higher than 33.11% of companies in Healthcare sector

    Profit

    Gross profit

    $5.82M
    DNTH annual gross profit is $5.82 million

    Gross margin

    93.39%
    DNTH annual gross profit margin is 93.39%

    Operating profit

    -$101.86M
    DNTH annual operating income is -$101.86 million

    Operating margin

    -1633.75%
    DNTH annual operating profit margin is -1633.75%

    Net income

    -$84.97M
    DNTH annual net profit is -$84.97 million

    Net margin

    -1362.77%
    DNTH annual net profit margin is -1362.77%

    Expenses

    Total expenses

    $91.20M
    DNTH annual total expenses is $91.20 million

    Operating expenses

    $107.69M
    DNTH annual total operating expenses is $107.69 million

    Cost of goods sold

    $412.00K
    DNTH annual cost of goods sold is $412.00 thousand

    Selling, general & administrative expenses

    $0.00
    DNTH annual SGA is $0.00

    Depreciation and amortization

    $412.00K
    DNTH annual depreciation & amortization is $412.00 thousand

    Interest expense

    $0.00
    DNTH annual interest expense is $0.00

    Income tax

    $0.00
    DNTH annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$101.86M
    DNTH annual earnings before interest & taxes is -$101.86 million

    EBITDA

    -$101.45M
    DNTH annual EBITDA is -$101.45 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $374.24M
    DNTH annual total assets is $374.24 million

    Non current assets

    $93.33M
    DNTH annual long term assets is $93.33 million

    Current assets

    $280.90M
    DNTH annual total current assets is $280.90 million

    Cash and cash equivalents

    $275.24M
    DNTH annual cash & cash equivalents is $275.24 million

    Accounts receivable

    $1.01M
    DNTH annual accounts receivable is $1.01 million

    Inventory

    $0.00
    DNTH annual inventory is $0.00

    Liabilities

    Total liabilities

    $21.76M
    DNTH annual total liabilities is $21.76 million

    Long term liabilities

    $3.31M
    DNTH annual total long term liabilities is $3.31 million

    Current liabilities

    $18.45M
    DNTH annual total current liabilities is $18.45 million

    Accounts payable

    $4.58M
    DNTH annual accounts payable is $4.58 million

    Debt

    Total debt

    $1.49M
    DNTH annual total debt is $1.49 million

    Total debt 1-year change

    +154.87%
    DNTH annual total debt is up +154.87% year-on-year

    Long term debt

    $1.17M
    DNTH annual long term debt is $1.17 million

    Short term debt

    $320.00K
    DNTH annual short term debt is $320.00 thousand

    Equity & Capital

    Shareholders equity

    $352.48M
    DNTH annual stockholders equity is $352.48 million

    Book value

    $352.48M
    DNTH annual book value is $352.48 million

    Retained earnings

    -$174.39M
    DNTH annual retained earnings is -$174.39 million

    Working capital

    $262.45M
    DNTH annual working capital is $262.45 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$78.18M
    DNTH annual cash flow from operations is -$78.18 million

    Cash from operations 1-year change

    -112.09%
    DNTH annual cash flow from operations is down -112.09% year-on-year

    Cash from investing

    -$286.81M
    DNTH annual cash flow from investing activities is -$286.81 million

    Cash from investing 1-year change

    -1516.15%
    DNTH annual cash flow from investing activities is down -1516.15% year-on-year

    Cash from financing

    $255.62M
    DNTH annual cash flow from financing activities is $255.62 million

    Cash from financing 1-year change

    +91.37%
    DNTH annual cash flow from financing activities is up +91.37% year-on-year

    CAPEX

    CAPEX

    $105.00K
    DNTH annual capital expenditures is $105.00 thousand

    CAPEX 1-year change

    -4.55%
    DNTH annual capital expenditures is down -4.55% year-on-year

    Free Cash Flow

    Free cash flow

    -$78.28M
    DNTH annual free cash flow is -$78.28 million

    Free cash flow 1-year change

    -111.75%
    DNTH annual free cash flow is down -111.75% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    93.39%
    DNTH annual gross profit margin is 93.39%

    Operating margin

    -1633.75%
    DNTH annual operating profit margin is -1633.75%

    Net margin

    -1362.77%
    DNTH annual net profit margin is -1362.77%

    ROA & ROE

    ROA

    -30.69%
    DNTH annual return on assets is -30.69%

    ROE

    -32.60%
    DNTH annual return on equity is -32.60%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    DNTH price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    DNTH price to earnings ratio is unknown

    PB Ratio

    PB ratio

    2.51
    DNTH price to book ratio is 2.51

    PB ratio Sector rank

    61.12%
    DNTH price to book ratio is higher than 61.12% of companies in Healthcare sector

    PS Ratio

    PS ratio

    156.83
    DNTH price to sales ratio is 156.83

    PS ratio Sector rank

    92.64%
    DNTH price to sales ratio is higher than 92.64% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $505.19M
    DNTH enterprise value is $505.19 million

    Enterprise value Sector rank

    66.95%
    DNTH enterprise value is higher than 66.95% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.90
    DNTH EV/EBITDA is -3.90

    EV/EBITDA Sector rank

    24.96%
    DNTH EV/EBITDA is higher than 24.96% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    15.22
    DNTH annual current ratio is 15.22

    Quick ratio

    15.22
    DNTH annual quick ratio is 15.22

    Leverage

    Debt to equity

    0.00
    DNTH annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    DNTH annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    1
    DNTH piotroski f-score is 1

    Altman Z-Score

    20.30
    DNTH altman z-score is 20.30

    Analyst ratings

    Recent major analysts updates

    Jul 2, 25 William Blair
    Outperform
    May 13, 25 HC Wainwright & Co.
    Buy
    May 13, 25 Baird
    Outperform
    Mar 12, 25 Wedbush
    Outperform
    Mar 12, 25 HC Wainwright & Co.
    Buy
    Mar 12, 25 Guggenheim
    Buy
    Dec 20, 24 TD Cowen
    Buy
    Nov 11, 24 Oppenheimer
    Outperform
    Nov 11, 24 HC Wainwright & Co.
    Buy
    Nov 8, 24 Raymond James
    Outperform

    Institutional Ownership

    Screeners with DNTH included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    • What is the ticker symbol for Dianthus Therapeutics, Inc.?
    • Does Dianthus Therapeutics, Inc. pay dividends?
    • What sector is Dianthus Therapeutics, Inc. in?
    • What industry is Dianthus Therapeutics, Inc. in?
    • What country is Dianthus Therapeutics, Inc. based in?
    • When did Dianthus Therapeutics, Inc. go public?
    • Is Dianthus Therapeutics, Inc. in the S&P 500?
    • Is Dianthus Therapeutics, Inc. in the NASDAQ 100?
    • Is Dianthus Therapeutics, Inc. in the Dow Jones?
    • When was Dianthus Therapeutics, Inc.'s last earnings report?
    • When does Dianthus Therapeutics, Inc. report earnings?

    What is the ticker symbol for Dianthus Therapeutics, Inc.?

    The ticker symbol for Dianthus Therapeutics, Inc. is NASDAQ:DNTH

    Does Dianthus Therapeutics, Inc. pay dividends?

    No, Dianthus Therapeutics, Inc. does not pay dividends

    What sector is Dianthus Therapeutics, Inc. in?

    Dianthus Therapeutics, Inc. is in the Healthcare sector

    What industry is Dianthus Therapeutics, Inc. in?

    Dianthus Therapeutics, Inc. is in the Biotechnology industry

    What country is Dianthus Therapeutics, Inc. based in?

    Dianthus Therapeutics, Inc. is headquartered in United States

    When did Dianthus Therapeutics, Inc. go public?

    Dianthus Therapeutics, Inc.'s initial public offering (IPO) was on June 21, 2018

    Is Dianthus Therapeutics, Inc. in the S&P 500?

    No, Dianthus Therapeutics, Inc. is not included in the S&P 500 index

    Is Dianthus Therapeutics, Inc. in the NASDAQ 100?

    No, Dianthus Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Dianthus Therapeutics, Inc. in the Dow Jones?

    No, Dianthus Therapeutics, Inc. is not included in the Dow Jones index

    When was Dianthus Therapeutics, Inc.'s last earnings report?

    Dianthus Therapeutics, Inc.'s most recent earnings report was on May 8, 2025

    When does Dianthus Therapeutics, Inc. report earnings?

    The next expected earnings date for Dianthus Therapeutics, Inc. is November 6, 2025
    On this page